Cannabinoids
"Cannabinoids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds having the cannabinoid structure. They were originally extracted from Cannabis sativa L. The most pharmacologically active constituents are TETRAHYDROCANNABINOL; CANNABINOL; and CANNABIDIOL.
Descriptor ID |
D002186
|
MeSH Number(s) |
D02.455.849.090
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cannabinoids".
Below are MeSH descriptors whose meaning is more specific than "Cannabinoids".
This graph shows the total number of publications written about "Cannabinoids" by people in this website by year, and whether "Cannabinoids" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 0 | 1 | 1 | 2010 | 0 | 1 | 1 | 2011 | 2 | 0 | 2 | 2012 | 5 | 0 | 5 | 2013 | 0 | 1 | 1 | 2014 | 1 | 1 | 2 | 2015 | 3 | 0 | 3 | 2016 | 3 | 1 | 4 | 2017 | 10 | 3 | 13 | 2018 | 2 | 2 | 4 | 2019 | 2 | 3 | 5 | 2020 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Cannabinoids" by people in Profiles.
-
Huestis MA, Sempio C, Newmeyer MN, Andersson M, Barnes AJ, Abulseoud OA, Blount BC, Schroeder J, Smith ML. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users. J Anal Toxicol. 2020 Oct 12; 44(7):651-660.
-
Vergara D, Gaudino R, Blank T, Keegan B. Modeling cannabinoids from a large-scale sample of Cannabis sativa chemotypes. PLoS One. 2020; 15(9):e0236878.
-
Lynn RSR, Galinkin JL. Cannabis, e-cigarettes and anesthesia. Curr Opin Anaesthesiol. 2020 Jun; 33(3):318-326.
-
Wagner S, Hoppe J, Zuckerman M, Schwarz K, McLaughlin J. Authors' response to "Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department". Clin Toxicol (Phila). 2020 09; 58(9):939.
-
Karoly HC, Mueller RL, Bidwell LC, Hutchison KE. Cannabinoids and the Microbiota-Gut-Brain Axis: Emerging Effects of Cannabidiol and Potential Applications to Alcohol Use Disorders. Alcohol Clin Exp Res. 2020 02; 44(2):340-353.
-
Sempio C, Lindley E, Klawitter J, Christians U, Bowler RP, Adgate JL, Allshouse W, Awdziejczyk L, Fischer S, Bainbridge J, Vandyke M, Netsanet R, Crume T, Kinney GL. Surface Detection of THC Attributable to Vaporizer Use in the Indoor Environment. Sci Rep. 2019 12 09; 9(1):18587.
-
Wagner S, Hoppe J, Zuckerman M, Schwarz K, McLaughlin J. Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department. Clin Toxicol (Phila). 2020 06; 58(6):471-475.
-
Bahouth MN, Kraus P, Dane K, Plazas Montana M, Tsao W, Tabaac B, Jasem J, Schmidlin H, Einstein E, Streiff MB, Shanbhag S. Synthetic cannabinoid-associated coagulopathy secondary to long-acting anticoagulant rodenticides: Observational case series and management recommendations. Medicine (Baltimore). 2019 Sep; 98(36):e17015.
-
Anderson SAR, Oprescu AM, Calello DP, Monte A, Dayan PS, Hurd YL, Manini AF. Neuropsychiatric Sequelae in Adolescents With Acute Synthetic Cannabinoid Toxicity. Pediatrics. 2019 08; 144(2).
-
Cogan PS. On healthcare by popular appeal: critical assessment of benefit and risk in cannabidiol based dietary supplements. Expert Rev Clin Pharmacol. 2019 Jun; 12(6):501-511.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|